← back to search

Prajnan Das

Houston Methodist · US
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research focused on Cancer and Total mesorectal excision, with related work in Colorectal cancer, Ramucirumab, Delphi method. Notable publications include 'Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology', 'Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology', and 'Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology'.
h-index
citations
6,402
works
22
NIH funding
primary concept
email

Recent publications

Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network 2025cited by 123position: middledoi
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2022cited by 1,680position: middledoi
Multi-organ segmentation of abdominal structures from non-contrast and contrast enhanced CT images
Scientific Reports 2022cited by 38position: middledoi
A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer
Journal of Gastrointestinal Oncology 2022cited by 28position: middledoi
Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy
Journal of Hepatocellular Carcinoma 2021cited by 46position: middledoi
The radiotherapy quality assurance gap among phase III cancer clinical trials
Radiotherapy and Oncology 2021cited by 27position: middledoi
Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline
Practical Radiation Oncology 2020cited by 141position: lastdoi
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials
European Journal of Cancer 2020cited by 67position: middledoi
Performance Status Restriction in Phase III Cancer Clinical Trials
Journal of the National Comprehensive Cancer Network 2020cited by 44position: middledoi
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2019cited by 1,094position: middledoi
Objective Evaluation of a Didactic Curriculum for the Radiation Oncology Medical Student Clerkship
International Journal of Radiation Oncology*Biology*Physics 2018cited by 35position: middledoi
Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2016cited by 952position: middledoi
International consensus guidelines on Clinical Target Volume delineation in rectal cancer
Radiotherapy and Oncology 2016cited by 244position: middledoi
Esophageal and Esophagogastric Junction Cancers, Version 1.2015
Journal of the National Comprehensive Cancer Network 2015cited by 652position: middledoi
Multi-Institutional Implementation and Evaluation of a Curriculum for the Medical Student Clerkship in Radiation Oncology
Journal of the American College of Radiology 2015cited by 33position: middledoi
Medical Student Perspectives on a Multi-institutional Clerkship Curriculum: A Report From the Radiation Oncology Education Collaborative Study Group
International Journal of Radiation Oncology*Biology*Physics 2015cited by 14position: middledoi
Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: Ten‐year institutional experience
Journal of Surgical Oncology 2014cited by 60position: middledoi
Gastric Cancer, Version 2.2013
Journal of the National Comprehensive Cancer Network 2013cited by 515position: middledoi
Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes
British journal of surgery 2013cited by 259position: middledoi
Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes
British journal of surgery 2013cited by 216position: middledoi
Metformin use and improved response to therapy in rectal cancer
Cancer Medicine 2013cited by 109position: lastdoi
ACR Appropriateness Criteria®  Resectable Rectal Cancer
Radiation Oncology 2012cited by 25position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Charles R. Thomas · Dartmouth College6 papers (2012–2020)Bruce D. Minsky · The University of Texas MD Anderson Cancer Center4 papers (2020–2021)Christopher H. Crane · Trinity College Dublin4 papers (2013–2022)Ethan B. Ludmir · The University of Texas MD Anderson Cancer Center4 papers (2020–2022)Miguel A. Rodrı́guez-Bigas · Houston Methodist4 papers (2012–2022)John M. Skibber · Roswell Park Comprehensive Cancer Center3 papers (2013–2022)Claus Rödel · Goethe University Frankfurt3 papers (2020–2021)Emmanouil Fokas · DKFZ-ZMBH Alliance3 papers (2020–2021)Marc E. Delclos · Houston Methodist3 papers (2013–2022)George J. Chang · The University of Texas MD Anderson Cancer Center3 papers (2013–2022)Clifton D. Fuller · The University of Texas MD Anderson Cancer Center3 papers (2020–2021)Albert C. Koong · The University of Texas MD Anderson Cancer Center3 papers (2012–2021)Cullen M. Taniguchi · The University of Texas MD Anderson Cancer Center3 papers (2020–2021)B.R. Mancini · Yale Cancer Center2 papers (2015–2015)Joseph M. Herman · Michigan Manufacturing Technology Center2 papers (2012–2021)Matt Wheatley · Medical College of Wisconsin2 papers (2015–2015) · 2 papers (2015–2015)Sunil Krishnan · The University of Texas Southwestern Medical Center2 papers (2014–2022)W. Ian P. Mainwaring · University of California, Los Angeles2 papers (2020–2020) · 2 papers (2015–2015)